132 related articles for article (PubMed ID: 9839685)
21. Edema-forming activity of bushmaster (Lachesis muta stenophrys) and Central American rattlesnake (Crotalus durissus durissus) venoms and neutralization by a polyvalent antivenom.
Lomonte B
Toxicon; 1985; 23(1):173-6. PubMed ID: 3992598
[TBL] [Abstract][Full Text] [Related]
22. Snake venomics of the South and Central American Bushmasters. Comparison of the toxin composition of Lachesis muta gathered from proteomic versus transcriptomic analysis.
Sanz L; Escolano J; Ferretti M; Biscoglio MJ; Rivera E; Crescenti EJ; Angulo Y; Lomonte B; Gutiérrez JM; Calvete JJ
J Proteomics; 2008 Apr; 71(1):46-60. PubMed ID: 18541473
[TBL] [Abstract][Full Text] [Related]
23. [Neutralization of toxic and enzyme activities of 4 venoms from snakes of Guatemala and Honduras by the polyvalent antivenin produced in Costa Rica].
Rojas G; Gutiérrez JM; Gené JA; Gómez M; Cerdas L
Rev Biol Trop; 1987 Jun; 35(1):59-67. PubMed ID: 3444924
[TBL] [Abstract][Full Text] [Related]
24. Horse IgG isotypes and cross-neutralization of two snake antivenoms produced in Brazil and Costa Rica.
Fernandes I; Lima EX; Takehara HA; Moura-da-Silva AM; Tanjoni I; Gutiérrez JM
Toxicon; 2000 May; 38(5):633-44. PubMed ID: 10673156
[TBL] [Abstract][Full Text] [Related]
25. Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom.
Gené JA; Roy A; Rojas G; Gutiérrez JM; Cerdas L
Toxicon; 1989; 27(8):841-8. PubMed ID: 2781583
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological study of edema and myonecrosis in mice induced by venom of the bushmaster snake (Lachesis muta muta) and its basic Asp49 phospholipase A(2) (LmTX-I).
Damico DC; da Cruz Höfling MA; Cintra M; Leonardo MB; Calgarotto AK; da Silva SL; Marangoni S
Protein J; 2008 Sep; 27(6):384-91. PubMed ID: 18766430
[TBL] [Abstract][Full Text] [Related]
27. Coagulant thrombin-like enzymes from the venoms of Brazilian and Peruvian bushmaster (Lachesis muta muta) snakes.
Magalhaes A; Ferreira RN; Richardson M; Gontijo S; Yarleque A; Magalhaes HP; Bloch C; Sanchez EF
Comp Biochem Physiol B Biochem Mol Biol; 2003 Oct; 136(2):255-66. PubMed ID: 14529751
[TBL] [Abstract][Full Text] [Related]
28. Mutacytin-1, a New C-Type Lectin-Like Protein from the Venezuelan Cuaima (
Zanotty Y; Álvarez M; Perdomo L; Sánchez EE; Giron ME; Jimenez JC; Suntravat M; Guerrero B; Ibarra C; Montero Y; Medina R; Navarrete LF; Rodríguez-Acosta A
Zebrafish; 2019 Aug; 16(4):379-387. PubMed ID: 31145051
[TBL] [Abstract][Full Text] [Related]
29. Potential Utilization of a Polysaccharide from the Marine Algae
da Silva ACR; Duarte MER; Noseda MD; Ferreira LG; Cassolato JEF; Sanchez EF; Fuly AL
Mar Drugs; 2018 Oct; 16(11):. PubMed ID: 30373238
[TBL] [Abstract][Full Text] [Related]
30. Sulfated Galactan from Palisada flagellifera Inhibits Toxic Effects of Lachesis muta Snake Venom.
da Silva AC; Ferreira LG; Duarte ME; Noseda MD; Sanchez EF; Fuly AL
Mar Drugs; 2015 Jun; 13(6):3761-75. PubMed ID: 26110897
[TBL] [Abstract][Full Text] [Related]
31. Proteomic and functional analyses of Lachesis acrochorda snake venom from the Valle del Cauca Department of Colombia.
Montoya-Gómez A; Osorno-Valencia D; Gómez-Díaz M; Bolívar-García W; Jiménez-Charris E
Acta Trop; 2023 May; 241():106895. PubMed ID: 36931336
[TBL] [Abstract][Full Text] [Related]
32. Biological and immunochemical characterization of Micrurus altirostris venom and serum neutralization of its toxic activities.
Moraes FV; Sousa-e-Silva MC; Barbaro KC; Leitão MA; Furtado MF
Toxicon; 2003 Jan; 41(1):71-9. PubMed ID: 12467664
[TBL] [Abstract][Full Text] [Related]
33. Snake venomics and antivenomics of Bothrops atrox venoms from Colombia and the Amazon regions of Brazil, Perú and Ecuador suggest the occurrence of geographic variation of venom phenotype by a trend towards paedomorphism.
Núñez V; Cid P; Sanz L; De La Torre P; Angulo Y; Lomonte B; Gutiérrez JM; Calvete JJ
J Proteomics; 2009 Nov; 73(1):57-78. PubMed ID: 19665598
[TBL] [Abstract][Full Text] [Related]
34. Functional characterization of a basic D49 phospholipase A2 (LmTX-I) from the venom of the snake Lachesis muta muta (bushmaster).
Damico DC; Bueno LG; Rodrigues-Simioni L; Marangoni S; da Cruz-Höfling MA; Novello JC
Toxicon; 2006 Jun; 47(7):759-65. PubMed ID: 16626776
[TBL] [Abstract][Full Text] [Related]
35. Protective action of N-acetyl-L-cysteine associated with a polyvalent antivenom on the envenomation induced by Lachesis muta muta (South American bushmaster) in rats.
Leão-Torres AG; Pires CV; Ribelato AC; Zerbinatti MC; Santarém CL; Nogueira RMB; Giometti IC; Giuffrida R; Silva EO; Gerez JR; Silva NJ; Rowan EG; Floriano RS
Toxicon; 2021 Jul; 198():36-47. PubMed ID: 33915137
[TBL] [Abstract][Full Text] [Related]
36. Individual variations in the protein profiles and functional activities of the eyelash palm pit-viper (Bothriechis schlegelii) venom from the Colombian southwest region.
Montealegre-Sánchez L; Montoya-Gómez A; Jiménez-Charris E
Acta Trop; 2021 Nov; 223():106113. PubMed ID: 34450060
[TBL] [Abstract][Full Text] [Related]
37. A snakebite caused by a bushmaster (Lachesis muta): report of a confirmed case in State of Pernambuco, Brazil.
Lima PH; Haddad Junior V
Rev Soc Bras Med Trop; 2015; 48(5):636-7. PubMed ID: 26516981
[TBL] [Abstract][Full Text] [Related]
38. Neutralization of the hemorrhagic activity of Bothrops and Lachesis snake venoms by a monoclonal antibody against mutalysin-II.
Estêvão-Costa MI; Martins MS; Sánchez EF; Diniz CR; Chávez-Olórtegui C
Toxicon; 2000 Jan; 38(1):139-44. PubMed ID: 10669019
[TBL] [Abstract][Full Text] [Related]
39. [Toxicity, neutralization and immunoelectrophoresis of the venom of Lachesis muta from Costa Rica and Colombia (author's transl)].
Bolaños R; Muñoz G; Cerdas L
Toxicon; 1978; 16(3):295-300. PubMed ID: 653757
[No Abstract] [Full Text] [Related]
40. Action of Varespladib (LY-315920), a Phospholipase A
Gutierres PG; Pereira DR; Vieira NL; Arantes LF; Silva NJ; Torres-Bonilla KA; Hyslop S; Morais-Zani K; Nogueira RMB; Rowan EG; Floriano RS
Front Pharmacol; 2021; 12():812295. PubMed ID: 35095526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
